Structures by: Jasinski J. P.
Total: 594
2-Chloro-<i>N</i>-[2-(2-fluorobenzoyl)-4-nitrophenyl]-<i>N</i>- methylacetamide
C16H12ClFN2O4
Acta Crystallographica Section E (2011) 67, 9 o2537-o2538
a=8.1339(6)Å b=10.9639(8)Å c=17.8690(11)Å
α=81.251(6)° β=82.239(6)° γ=87.937(6)°
<i>N</i>,<i>N</i>-Dimethyl-3-oxo-3-(thiophen-2-yl)propanaminium chloride
C9H14NOS,Cl
Acta Crystallographica Section E (2011) 67, 9 o2271
a=5.8663(3)Å b=27.0109(9)Å c=7.1385(4)Å
α=90.00° β=110.767(6)° γ=90.00°
2-[(<i>E</i>)-1-(4-methylphenyl)-3-(pyrrolidin-1-ium- 1-yl)prop-1-enyl]pyridinium bis(2,4,6-trinitrophenolate)
C19H24N22,2(C6H2N3O7)
Acta Crystallographica Section E (2011) 67, 9 o2502
a=15.0542(7)Å b=12.7489(5)Å c=17.1446(7)Å
α=90.00° β=100.218(4)° γ=90.00°
[3-(5-Hydroxy-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>]cyclohepten-5- yl)propyl]dimethylammonium 3-carboxyprop-2-enoate
C20H24NO,C4H3O4
Acta Crystallographica Section E (2011) 67, 10 o2600-o2601
a=9.2115(2)Å b=11.5840(2)Å c=10.4640(2)Å
α=90.00° β=101.591(2)° γ=90.00°
<i>N</i>-(4-Chloro-1,3-benzothiazol-2-yl)-2-(3-methylphenyl)acetamide monohydrate
C16H13ClN2OS,H2O
Acta Crystallographica Section E (2011) 67, 10 o2602-o2603
a=7.2771(3)Å b=9.2568(5)Å c=12.0851(5)Å
α=83.948(4)° β=84.306(3)° γ=72.133(4)°
2-Phenyl-3-(trimethylsilyl)propan-1-aminium chloride
C12H22NSi,Cl
Acta Crystallographica Section E (2011) 67, 10 o2553
a=12.3716(4)Å b=32.6920(8)Å c=7.44256(18)Å
α=90.00° β=93.006(2)° γ=90.00°
2-(4-Hydroxyphenyl)-3-(trimethylsilyl)propanaminium chloride
C12H22NOSi,Cl
Acta Crystallographica Section E (2011) 67, 10 o2694
a=14.2611(4)Å b=6.7587(2)Å c=16.0316(9)Å
α=90.00° β=91.252(3)° γ=90.00°
<i>N</i>-(3-Chloro-4-fluorophenyl)-2,2-diphenylacetamide
C20H15ClFNO
Acta Crystallographica Section E (2011) 67, 10 o2604
a=9.3665(17)Å b=10.2069(12)Å c=9.7774(16)Å
α=90.00° β=114.42(2)° γ=90.00°
3-Chloroanilinium 4-methylbenzenesulfonate
C6H7ClN,C7H7O3S
Acta Crystallographica Section E (2011) 67, 11 o2925
a=12.7848(3)Å b=6.7767(2)Å c=16.1702(4)Å
α=90.00° β=105.081(2)° γ=90.00°
1-(4,6-Dimethylpyrimidin-2-yl)thiourea
C7H10N4S
Acta Crystallographica Section E (2011) 67, 12 o3347
a=8.3372(5)Å b=15.8303(10)Å c=6.6180(10)Å
α=90.00° β=90.00° γ=90.00°
1,2-Bis(3-phenoxybenzylidene)hydrazine
C26H20N2O2
Acta Crystallographica Section E (2012) 68, 1 o81
a=23.6271(16)Å b=11.2942(6)Å c=8.2359(7)Å
α=90.00° β=109.538(8)° γ=90.00°
<i>N</i>-(4,6-Dimethoxypyrimidin-2-yl)-2-(3-methylphenyl)acetamide
C15H17N3O3
Acta Crystallographica Section E (2012) 68, 1 o226-o227
a=7.1536(6)Å b=8.2070(7)Å c=13.8259(10)Å
α=74.420(7)° β=86.540(6)° γ=69.186(8)°
1,2-Bis[(1,3-benzodioxol-5-yl)methylidene]hydrazine
C16H12N2O4
Acta Crystallographica Section E (2012) 68, 1 o7
a=6.1835(2)Å b=4.5970(2)Å c=23.8487(10)Å
α=90.00° β=96.080(4)° γ=90.00°
Loperamide monohydrate
C29H33ClN2O2,H2O
Acta Crystallographica Section E (2012) 68, 2 o539-o540
a=16.7869(4)Å b=15.1506(6)Å c=20.6617(6)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>)-1-(2,6-Dichloro-3-fluorophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
C16H11Cl2FO2
Acta Crystallographica Section E (2012) 68, 4 o1163
a=11.9035(6)Å b=10.4472(5)Å c=23.7435(12)Å
α=90.00° β=92.296(4)° γ=90.00°
5-(Thiophen-2-ylmethyl)-1,3,4-thiadiazol-2-amine
C7H7N3S2
Acta Crystallographica Section E (2012) 68, 5 o1279
a=11.2970(6)Å b=6.6094(3)Å c=11.2480(6)Å
α=90.00° β=97.243(5)° γ=90.00°
<i>N</i>,<i>N</i>-Dicyclohexylcyclohexanecarboxamide
C19H33NO
Acta Crystallographica Section E (2012) 68, 7 o2215
a=9.8237(3)Å b=16.8736(5)Å c=10.8886(3)Å
α=90.00° β=102.890(3)° γ=90.00°
1-{4-[Bis(4-fluorophenyl)methyl]piperazin-1-yl}ethanone
C19H20F2N2O
Acta Crystallographica Section E (2012) 68, 7 o2237
a=10.1701(5)Å b=16.5521(5)Å c=11.1690(5)Å
α=90.0° β=114.690(5)° γ=90.0°
<i>N</i>-Ethyl-2-[1-(2-hydroxy-6- methoxyphenyl)ethylidene]hydrazinecarbothioamide
C12H17N3O2S
Acta Crystallographica Section E (2012) 68, 10 o2982
a=8.5681(6)Å b=8.0393(5)Å c=10.3808(8)Å
α=90.0° β=103.510(7)° γ=90.0°
[2-(Biphenyl-4-yl)-1,3-thiazol-4-yl]methanol
C16H13NOS
Acta Crystallographica Section E (2012) 68, 10 o2950
a=6.05424(18)Å b=29.3096(9)Å c=7.2064(2)Å
α=90.00° β=92.668(3)° γ=90.00°
<i>N</i>,<i>N</i>'-Dibenzyl-<i>N</i>''-(2-chloro-2,2-difluoroacetyl)phosphoric triamide
C16H17ClF2N3O2P
Acta Crystallographica Section E (2012) 68, 10 o3009
a=12.9734(5)Å b=4.9900(2)Å c=13.7750(4)Å
α=90.00° β=96.482(3)° γ=90.00°
1-Butyl-3-ethyl-1<i>H</i>-benzimidazol-3-ium tetrafluoroborate
C13H19N2,BF4
Acta Crystallographica Section E (2012) 68, 10 o2862
a=11.0043(13)Å b=12.0372(9)Å c=11.3693(10)Å
α=90.00° β=99.312(9)° γ=90.00°
(<i>E</i>)-<i>N</i>'-(4-Methoxybenzylidene)-2-<i>m</i>-tolylacetohydrazide
C17H18N2O2
Acta Crystallographica Section E (2012) 68, 12 o3435
a=6.4961(8)Å b=9.8047(10)Å c=12.7464(13)Å
α=112.130(9)° β=95.507(10)° γ=96.601(9)°
2-(2-Nitrophenyl)acetohydrazide
C8H9N3O3
Acta Crystallographica Section E (2012) 68, 12 o3436
a=6.6962(5)Å b=4.9388(4)Å c=13.3593(12)Å
α=90.00° β=92.361(8)° γ=90.00°
2-(4-Methylphenyl)acetohydrazide
C9H12N2O
Acta Crystallographica Section E (2012) 68, 12 o3467
a=15.4261(16)Å b=6.2618(7)Å c=9.2073(10)Å
α=90.00° β=106.651(12)° γ=90.00°
Orphenadrinium dihydrogen citrate
C18H24NO,C6H7O7
Acta Crystallographica Section E (2013) 69, 2 o248
a=9.9515(8)Å b=10.7382(9)Å c=12.6250(10)Å
α=98.863(7)° β=104.391(7)° γ=111.498(8)°
Ethyl 6-(6-methoxynaphthalen-2-yl)-4-(naphthalen-2-yl)-2-oxocyclohex-3-ene-1-carboxylate
C30H26O4
Acta Crystallographica Section E (2013) 69, 3 o352
a=18.4688(10)Å b=11.2940(6)Å c=10.9676(5)Å
α=90.00° β=96.082(5)° γ=90.00°
(<i>E</i>)-<i>N</i>'-(4-Fluorobenzylidene)-2-(3-methylphenyl)acetohydrazide
C16H15FN2O
Acta Crystallographica Section E (2013) 69, 3 o421
a=11.8535(7)Å b=12.3769(9)Å c=20.8721(11)Å
α=98.549(5)° β=103.074(5)° γ=105.134(6)°
<i>N</i>-(4-Bromophenyl)acetamide
C8H8BrNO
Acta Crystallographica Section E (2013) 69, 3 o461
a=6.7250(7)Å b=9.3876(11)Å c=14.4434(14)Å
α=90.00° β=117.750(4)° γ=90.00°
2-(2,6-Dichlorophenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C11H8Cl2N2OS
Acta Crystallographica Section E (2013) 69, 4 o523
a=7.1278(4)Å b=8.4434(4)Å c=10.3637(6)Å
α=95.341(4)° β=106.140(5)° γ=96.745(4)°
(<i>Z</i>)-4-[2-(2,4-Dimethylphenyl)hydrazinylidene]-3-methylpyrazol-5(1<i>H</i>)-one
C12H14N4O
Acta Crystallographica Section E (2013) 69, 4 o532
a=5.2926(2)Å b=22.1675(6)Å c=10.0529(3)Å
α=90.00° β=101.770(3)° γ=90.00°
4-Amino-<i>N</i>-<i>tert</i>-butyl-5-oxo-3-(propan-2-yl)-1<i>H</i>-1,2,4-triazole-1-carboxamide
C10H19N5O2
Acta Crystallographica Section E (2013) 69, 4 o603
a=11.0298(2)Å b=12.2135(4)Å c=14.8542(4)Å
α=92.244(2)° β=95.7020(19)° γ=93.379(2)°
Cinnarizinium bis(<i>p</i>-toluenesulfonate) dihydrate
C26H30N22,2(C7H7O3S),2(H2O)
Acta Crystallographica Section E (2013) 69, 4 o485-o486
a=10.0845(2)Å b=14.6026(3)Å c=25.8591(6)Å
α=90.00° β=93.414(2)° γ=90.00°
2-Isopropyl-5-methylcyclohexyl quinoline-2-carboxylate
C20H25NO2
Acta Crystallographica Section E (2014) 70, 1 o35-o36
a=9.31412(17)Å b=11.9669(2)Å c=15.4894(3)Å
α=90° β=90° γ=90°
4-Amino-3-(4-hydroxybenzyl)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C9H10N4OS
Acta Crystallographica Section E (2014) 70, 1 o48-o49
a=4.2117(5)Å b=6.1891(7)Å c=10.0641(11)Å
α=100.590(9)° β=94.916(9)° γ=104.589(10)°
4-[(<i>E</i>)-(4-Chlorobenzylidene)amino]-3-methyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C10H9ClN4S
Acta Crystallographica Section E (2014) 70, 1 o57-o58
a=7.0718(8)Å b=7.2901(8)Å c=11.8434(7)Å
α=92.778(7)° β=94.986(7)° γ=109.752(10)°
(4-Methylpiperazin-1-yl)-(2,3,4-trimethoxybenzylidene)amine
C15H23N3O3
Acta Crystallographica Section E (2014) 70, 4 o500
a=7.84207(14)Å b=14.2305(3)Å c=27.6218(5)Å
α=90° β=90° γ=90°
6-Chloro-2-chloromethyl-4-phenylquinazoline 3-oxide
C15H10Cl2N2O
Acta Crystallographica Section E (2014) 70, 4 o440-o441
a=8.2030(3)Å b=14.3203(5)Å c=11.8477(4)Å
α=90° β=105.016(4)° γ=90°
{2-[(1<i>H</i>-Indol-3-ylmethylidene)amino]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-3-yl}(phenyl)methanone
C24H20N2OS
Acta Crystallographica Section E (2014) 70, 4 o501-o502
a=8.66858(16)Å b=21.8200(4)Å c=10.41956(18)Å
α=90° β=108.1709(19)° γ=90°
(<i>E</i>)-2-{[(Furan-2-ylmethyl)imino]methyl}-4-nitrophenol
C12H10N2O4
Acta Crystallographica Section E (2014) 70, 4 o451-o452
a=5.4427(7)Å b=8.2488(10)Å c=12.4701(14)Å
α=98.901(9)° β=92.040(10)° γ=91.690(10)°
{2-[(2-Hydroxy-benzylidene)-amino]-4,5,6,7-tetrahydro-benzo[b]thiophen-3-yl}- phenyl-methanone
C22H19NO2S
Acta Crystallographica Section E (2014) 70, 4 o476-o477
a=9.26395(15)Å b=14.2886(2)Å c=13.6476(2)Å
α=90° β=96.7581(15)° γ=90°
5-(4-fluoro-phenyl)-2H-pyrazol-1-ium trifluoro-acetate
C9H8FN2,C2F3O2
Acta Crystallographica Section E (2014) 70, 4 o429-o430
a=6.7828(2)Å b=16.8263(6)Å c=10.4004(4)Å
α=90° β=93.354(3)° γ=90°
[2-(Benzylideneamino)-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-3-yl](phenyl)methanone
C22H19NOS
Acta Crystallographica Section E (2014) 70, 5 o507-o508
a=8.78760(16)Å b=14.0091(3)Å c=14.4120(2)Å
α=90° β=94.8913(17)° γ=90°
{2-[(2-Bromo-5-methoxybenzylidene)amino]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-3-yl}(phenyl)methanone
C23H20BrNO2S
Acta Crystallographica Section E (2014) 70, 5 o581-o582
a=8.84813(17)Å b=12.5563(2)Å c=18.4384(4)Å
α=90° β=102.363(2)° γ=90°
(<i>Z</i>)-1-Diphenylmethyl-4-(3-phenylprop-2-enyl)piperazine
C26H28N2
Acta Crystallographica Section E (2014) 70, 5 o576
a=8.7823(3)Å b=9.6068(3)Å c=12.4894(4)Å
α=90° β=94.834(3)° γ=90°
1-3-aminopropyl imidazolium 3,5- dinitrosalicylate
C6H12N3,C7H3N2O7
Acta Crystallographica Section E (2014) 70, 3 o318-o319
a=7.0109(4)Å b=10.6617(8)Å c=10.7454(7)Å
α=93.075(6)° β=95.863(5)° γ=104.944(6)°
1-Piperonylpiperazinium p-chlorobenzoate
C12H17N2O2,C7H4ClO2
Acta Crystallographica Section E (2014) 70, 3 o283-o284
a=16.9967(6)Å b=8.5990(3)Å c=12.4150(5)Å
α=90° β=90.923(3)° γ=90°
1-(3,4-Dimethoxyphenyl)-3-phenylprop-2-en-1-one
C17H16O3
Acta Crystallographica Section E (2014) 70, 3 o368
a=7.3269(7)Å b=9.8923(11)Å c=10.7668(11)Å
α=102.408(9)° β=109.255(9)° γ=98.951(9)°
Bruceolline J
C13H13NO2
Acta Crystallographica Section E (2013) 69, 8 o1351-o1352
a=8.2951(3)Å b=12.3070(4)Å c=10.7340(4)Å
α=90° β=97.207(3)° γ=90°
2-{(4-Chlorophenyl)[2-(dimethylazaniumyl)ethoxy]methyl}pyridinium bis(2,4,6-trinitrophenolate)
C16H21ClN2O2,2(C6H2N3O7)
Acta Crystallographica Section E (2013) 69, 8 o1264-o1265
a=8.1719(6)Å b=8.5341(6)Å c=23.5868(16)Å
α=83.771(6)° β=85.484(6)° γ=74.827(6)°
Flunarizinium hydrogen maleate
C26H27F2N2,C4H3O4
Acta Crystallographica Section E (2013) 69, 8 o1344
a=22.1215(5)Å b=10.8620(2)Å c=11.3215(2)Å
α=90° β=98.879(2)° γ=90°
2-[1-(2-Hydroxy-4-methoxyphenyl)ethylidene]-<i>N</i>-methylhydrazinecarbothioamide
C11H15N3O2S
Acta Crystallographica Section E (2013) 69, 8 o1315
a=10.9881(8)Å b=9.1468(6)Å c=12.5575(9)Å
α=90° β=109.400(8)° γ=90°
2-(3,4-Dichlorophenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C11H8Cl2N2OS
Acta Crystallographica Section E (2013) 69, 5 o645-o646
a=4.6185(3)Å b=7.7741(7)Å c=17.1188(12)Å
α=100.278(7)° β=94.250(6)° γ=105.001(7)°
2-(4-Chlorophenyl)-<i>N</i>-(3,4-difluorophenyl)acetamide
C14H10ClF2NO
Acta Crystallographica Section E (2013) 69, 6 o996-o997
a=4.8935(5)Å b=5.8995(6)Å c=42.572(4)Å
α=90° β=90° γ=90°
(2<i>E</i>)-1-(4-Chlorophenyl)-3-(4-nitrophenyl)prop-2-en-1-one
C15H10ClNO3
Acta Crystallographica Section E (2013) 69, 5 o790-o791
a=42.9266(17)Å b=5.9741(3)Å c=5.0680(2)Å
α=90° β=90° γ=90°
2-(2,4-Dichlorophenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C11H8Cl2N2OS
Acta Crystallographica Section E (2013) 69, 5 o656-o657
a=5.3262(2)Å b=10.5083(4)Å c=10.8096(4)Å
α=83.900(3)° β=86.301(3)° γ=87.279(4)°
4-Hydroxy-<i>N</i>-methylbenzamide
C8H9NO2
Acta Crystallographica Section E (2013) 69, 5 o738
a=13.576(3)Å b=16.964(3)Å c=11.025(2)Å
α=90° β=120.11(3)° γ=90°
2-(4-Bromophenyl)-<i>N</i>-(3,4-difluorophenyl)acetamide
C14H10BrF2NO
Acta Crystallographica Section E (2013) 69, 6 o900-o901
a=4.9136(3)Å b=6.0218(4)Å c=42.514(2)Å
α=90° β=90° γ=90°
Rupatidine
C26H26ClN3
Acta Crystallographica Section E (2013) 69, 6 o980
a=10.2655(3)Å b=11.3341(4)Å c=18.8111(6)Å
α=90° β=90.874(3)° γ=90°
Methyl 2-{2-[(2-methylphenoxy)methyl]phenyl}-2-oxoacetate
C17H16O4
Acta Crystallographica Section E (2013) 69, 5 o671
a=31.6697(11)Å b=7.5883(2)Å c=12.5915(6)Å
α=90° β=108.514(4)° γ=90°
(2<i>S</i>*,5<i>R</i>*)-2,5-Dimethyl-1,4-bis(pyridin-2-ylmethyl)piperazine
C18H24N4
Acta Crystallographica Section E (2013) 69, 7 o1101
a=9.4097(5)Å b=9.2191(5)Å c=18.7473(9)Å
α=90° β=90° γ=90°
2-[(2-Chlorophenyl)(hydroxy)methyl]phenol
C13H11ClO2
Acta Crystallographica Section E (2013) 69, 8 o1240
a=23.4627(8)Å b=23.4627(8)Å c=11.3722(4)Å
α=90° β=90° γ=120°
Methyl 2-[4-(trifluoromethyl)phenylsulfanyl]benzoate
C15H11F3O2S
Acta Crystallographica Section E (2013) 69, 11 o1670
a=11.0675(5)Å b=8.0429(3)Å c=15.6614(7)Å
α=90° β=96.654(5)° γ=90°
4-Methyl-<i>N</i>-(4-nitrobenzylidene)piperazin-1-amine
C12H16N4O2
Acta Crystallographica Section E (2013) 69, 11 o1687-o1688
a=27.9353(14)Å b=5.9247(3)Å c=18.7763(7)Å
α=90° β=126.527(3)° γ=90°
4-(3-Fluoro-4-methylanilino)-2-methylidene-4-oxobutanoic acid
C12H12FNO3
Acta Crystallographica Section E (2013) 69, 12 o1752
a=6.3368(3)Å b=8.2642(4)Å c=21.0277(11)Å
α=84.057(4)° β=89.798(4)° γ=86.062(4)°
4-Chloro-3-methylphenyl quinoline-2-carboxylate
C17H12ClNO2
Acta Crystallographica Section E (2013) 69, 12 o1842-o1843
a=7.75379(16)Å b=11.9658(3)Å c=14.9005(3)Å
α=90° β=90° γ=90°
4-Chlorophenyl quinoline-2-carboxylate
C16H10ClNO2
Acta Crystallographica Section E (2013) 69, 12 o1841
a=6.38693(18)Å b=16.8893(5)Å c=12.2649(4)Å
α=90° β=103.527(3)° γ=90°
Ethyl 6-(4-chlorophenyl)-4-(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate
C21H18ClFO3
Acta Crystallographica Section E (2013) 69, 12 o1839-o1840
a=11.6611(5)Å b=13.1823(5)Å c=13.2251(5)Å
α=77.250(3)° β=87.320(3)° γ=67.342(4)°
Methyl 1-benzyl-5-methyl-2,4-diphenyl-1<i>H</i>-pyrrole-3-carboxylate
C26H23NO2
Acta Crystallographica Section E (2014) 70, 3 o338-o339
a=8.8056(2)Å b=10.6638(2)Å c=21.8315(5)Å
α=90° β=90° γ=90°
1-Piperonylpiperazinium 4-nitrobenzoate monohydrate
C12H17N2O2,C7H4NO4,H2O
Acta Crystallographica Section E (2014) 70, 3 o270-o271
a=6.0745(5)Å b=12.0617(11)Å c=13.4817(10)Å
α=92.561(7)° β=98.753(7)° γ=93.326(7)°
(<i>E</i>)-2-{[4-(Dimethylamino)benzylidene]amino}-5-nitrophenol
C15H15N3O3
Acta Crystallographica Section E (2014) 70, 5 o598-o599
a=6.1435(3)Å b=14.3844(8)Å c=15.8516(9)Å
α=108.038(5)° β=91.258(4)° γ=96.033(4)°
<i>N</i>-[3-(2-Chlorobenzoyl)-5-ethylthiophen-2-yl]-2-[(<i>E</i>)-(2-hydroxybenzylidene)amino]acetamide
C22H19ClN2O3S
Acta Crystallographica Section E (2014) 70, 9 o1011-o1012
a=9.7888(2)Å b=16.9476(3)Å c=12.2863(3)Å
α=90° β=90.6654(19)° γ=90°
3-[4-(Pyrimidin-2-yl)piperazin-1-ium-1-yl]butanoate
C12H18N4O2
Acta Crystallographica Section E (2014) 70, 9 o1063-o1064
a=13.5157(6)Å b=7.8454(3)Å c=12.2147(5)Å
α=90° β=106.884(5)° γ=90°
4-(Pyrimidin-2-yl)piperazin-1-ium chloride
C8H13N4,Cl
Acta Crystallographica Section E (2014) 70, 10 203-206
a=6.84764(17)Å b=7.27667(18)Å c=19.1751(5)Å
α=90° β=90° γ=90°
4-(Pyrimidin-2-yl)piperazin-1-ium nitrate
C8H13N4,NO3
Acta Crystallographica Section E (2014) 70, 10 203-206
a=10.5272(6)Å b=7.2230(3)Å c=14.1575(7)Å
α=90° β=107.341(6)° γ=90°
C29H30N2O2S
C29H30N2O2S
The Journal of organic chemistry (2016) 81, 13 5362-5369
a=8.4691(3)Å b=16.8355(8)Å c=19.8840(7)Å
α=90° β=90.960(3)° γ=90°
C29H29BrN2O7
C29H29BrN2O7
The Journal of organic chemistry (2018) 83, 21 13536-13542
a=14.6471(3)Å b=9.8270(2)Å c=19.3981(3)Å
α=90° β=104.564(2)° γ=90°
C27H25BrN2O6
C27H25BrN2O6
The Journal of organic chemistry (2018) 83, 21 13536-13542
a=6.1480(3)Å b=9.3553(7)Å c=21.4639(14)Å
α=97.508(6)° β=91.047(5)° γ=93.474(5)°
C17H11F8N
C17H11F8N
The Journal of organic chemistry (2015) 80, 3 1523-1532
a=12.154(3)Å b=9.965(3)Å c=12.740(3)Å
α=90° β=101.872(19)° γ=90°
00067z
C21H12F8O
The Journal of organic chemistry (2015) 80, 3 1523-1532
a=9.8175(10)Å b=13.2951(14)Å c=13.3177(14)Å
α=90° β=90.978(2)° γ=90°
C18H23NO5
C18H23NO5
Journal of Organic Chemistry (2006) 71, 8140-8145
a=10.849(5)Å b=16.398(3)Å c=9.710(6)Å
α=90.0000° β=90.0000° γ=90.0000°
C18H22N5O7
C18H22N5O7
Journal of Organic Chemistry (2006) 71, 8140-8145
a=8.384(4)Å b=20.291(5)Å c=6.443(4)Å
α=90.29(2)° β=112.06(3)° γ=89.876(9)°
C10H11NO2
C10H11NO2
Inorganic Chemistry (2004) 43, 5704-5713
a=9.0577(8)Å b=10.6520(10)Å c=9.6107(9)Å
α=90.00° β=101.457(2)° γ=90.00°
C22H24MoN2O6
C22H24MoN2O6
Inorganic Chemistry (2004) 43, 5704-5713
a=10.585(2)Å b=14.807(3)Å c=27.670(6)Å
α=90.00° β=90.00° γ=90.00°
C20H20N2O5V
C20H20N2O5V
Inorganic Chemistry (2004) 43, 5704-5713
a=8.8894(6)Å b=11.7764(9)Å c=18.1078(14)Å
α=90.00° β=90.00° γ=90.00°
C22H24N2O5V
C22H24N2O5V
Inorganic Chemistry (2004) 43, 5704-5713
a=11.8441(6)Å b=9.2827(5)Å c=19.8234(10)Å
α=90.00° β=93.0430(10)° γ=90.00°
C22H23MnN2O6
C22H23MnN2O6
Inorganic Chemistry (2004) 43, 5704-5713
a=14.134(8)Å b=9.851(10)Å c=15.474(15)Å
α=90.00° β=107.872(17)° γ=90.00°
C14H28CuIN4S2
C14H28CuIN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=7.4901(4)Å b=10.3906(4)Å c=14.1896(8)Å
α=102.429(4)° β=100.467(5)° γ=100.840(4)°
Compound 6
C22H18CuN6O3S
RSC Adv. (2015)
a=7.9073(4)Å b=11.5507(6)Å c=14.2629(8)Å
α=104.034(5)° β=104.217(5)° γ=100.871(5)°
4-Amino-5-chloro-2,6-dimethylpyridin-1-ium 5-chloro-2-hydroxybenzoate
C6H9ClN3,C7H4ClO3
Acta Crystallographica Section C (2017) 73, 11 862-868
a=24.7483(12)Å b=6.9525(3)Å c=18.1423(8)Å
α=90° β=111.500(3)° γ=90°
<i>N</i>-(4-Bromo-3-methylphenyl)-2-phenylacetamide
C15H14BrNO
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 889-894
a=4.9995(3)Å b=10.8392(4)Å c=12.7301(7)Å
α=108.149(4)° β=91.968(5)° γ=90.310(4)°
N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)- 2-phenylacetamide
C19H19N3O2
Acta Crystallographica Section E (2013) 69, 12 o1726-o1727
a=10.1258(7)Å b=10.4671(8)Å c=17.8888(12)Å
α=100.833(6)° β=92.527(5)° γ=116.812(7)°
C30H16Fe2N2O14
C30H16Fe2N2O14
Organometallics (2006) 25, 15 3787
a=9.248(3)Å b=11.433(3)Å c=14.689(4)Å
α=104.220(5)° β=102.548(5)° γ=94.062(5)°
C10H6Br4Cl2N2
C10H6Br4Cl2N2
Chemical Communications (1999) 21 2195-2196
a=12.438(6)Å b=8.753(6)Å c=13.696(3)Å
α=90° β=90° γ=90°